These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2595593)

  • 21. [Dilated myocardiopathies: the relationship between the degree of cardiac dysfunction and ventricular arrhythmias. A clinical follow-up].
    Abreu A; Pereira H; Catarino C; Branco L; Valério L; Nunes H; Gonçalves JM; Gracias R; Antunes AM
    Rev Port Cardiol; 1993 Jan; 12(1):8, 33-7. PubMed ID: 8517976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immune status of patients with cardiac arrhythmias: idiopathic and in primary heart disease].
    Bekbosynova MS; Pichugin AV; Novikova DS; Gabrusenko SA; Kozhemiakina ESh; Ataullakhanova DM; Golitsyn SP; Ataullakhanov RI
    Ter Arkh; 2006; 78(9):52-60. PubMed ID: 17076226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sudden death in hypertrophic and dilated cardiomyopathies].
    Koga Y; Kihara K; Tsubaki K
    Kokyu To Junkan; 1989 Mar; 37(3):251-6. PubMed ID: 2734502
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic indications for sotalol 160 mg].
    Ginestes J
    Ann Cardiol Angeiol (Paris); 1985 Jan; 34(1):45-52. PubMed ID: 2579609
    [No Abstract]   [Full Text] [Related]  

  • 25. Review: Metabolic cardiomyopathy and conduction system defects in children.
    Gilbert-Barness E
    Ann Clin Lab Sci; 2004; 34(1):15-34. PubMed ID: 15038665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different criteria of cardiac resynchronization therapy and their prognostic value for worsening heart failure or major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Fauchier L; Poret P; Robin I; de Labriolle A; Giraudeau C; Cosnay P; Babuty D
    Am J Cardiol; 2006 Feb; 97(3):393-9. PubMed ID: 16442403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arrhythmic syndrome in hypertrophic cardiomyopathy].
    Storozhakov GI; Kisliak OA; Tsiurupa TP
    Sov Med; 1987; (2):5-8. PubMed ID: 3576317
    [No Abstract]   [Full Text] [Related]  

  • 29. Congestive heart failure in dialysis patients.
    Parfrey PS; Harnett JD; Griffiths SM; Gault MH; Barré PE
    Arch Intern Med; 1988 Jul; 148(7):1519-25. PubMed ID: 3382298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence and clinical significance of development of conduction disturbances in patients with hypertrophic cardiomyopathy].
    Suwa M; Hirota Y; Nakayama Y; Yoneda Y; Kusukawa J; Nakayama A; Kawamura K
    J Cardiol; 1989 Mar; 19(1):147-53. PubMed ID: 2810034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inclusion of electric disturbance type cardiomyopathy in the classification of cardiomyopathy: a current review.
    Sekiguchi M; Hasegawa A; Hiroe M; Morimoto S; Nishikawa T
    J Cardiol; 2008 Apr; 51(2):81-8. PubMed ID: 18522780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The course and prognosis of cardiomyopathies].
    Tereshchuk MG; Grinberg GE
    Klin Med (Mosk); 1991 Mar; 69(3):18-23. PubMed ID: 2067329
    [No Abstract]   [Full Text] [Related]  

  • 33. [The chronic effect of coenzyme Q10 in dilated cardiomyopathy: echocardiographic assessment].
    Nakanishi M; Yokota Y; Fukuzaki H
    Kokyu To Junkan; 1988 Jun; 36(6):655-60. PubMed ID: 3217604
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of hypertrophic cardiomyopathy with a combination of carnitine and beta blockaders. Review of the literature. Description of a clinical case and long-term follow up].
    Ferro M; Crivello R; Gianotti A; Conti M
    Clin Ter; 1993 Aug; 143(2):109-13. PubMed ID: 7900952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Disorders of the heart rhythm in dilated cardiomyopathy].
    Dauletbaeva SM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):97-8. PubMed ID: 6508938
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevalence and reproducibility of ventricular arrhythmias in patients with hypertrophic cardiomyopathy].
    Sanchís Fores J; Ruiz Granell R; García Civera R; Frasquet C; Losada A; Musoles S; Morell S; López Morino V
    Rev Esp Cardiol; 1988; 41(6):343-8. PubMed ID: 3262897
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ventricular tachyarrhythmias in patients with cardiomyopathy].
    Henningsen K; Christensen AH; Svendsen JH
    Ugeskr Laeger; 2008 Jun; 170(25):2238-42. PubMed ID: 18565313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The comparative morphological and morphometric characteristics of the myocardium in patients with a clinical diagnosis of hypertrophic cardiomyopathy].
    Tsyplenkova VG; Beskrovnova NN
    Arkh Patol; 1993; 55(3):26-9. PubMed ID: 7944964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of arrhythmias in hypertrophic cardiomyopathy].
    Rapezzi C; Spirito P
    G Ital Cardiol; 1995 Nov; 25(11):1443-6. PubMed ID: 8682242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.